Estrella Immunopharma, Inc.
ESLA
$1.07
-$0.07-5.75%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/18/2026
-
The Cerbat Gem
5/5/2026
-
Business Wire
4/26/2026
-
MarketBeat
4/8/2026
-
MarketBeat
3/23/2026
-
Business Wire
3/4/2026
-
Ticker Report
2/9/2026
-
MarketBeat
2/9/2026
-
TipRanks Financial Blog
2/9/2026
-
The Fly
2/9/2026
-
Business Wire
2/3/2026
-
Business Wire
1/13/2026
-
TipRanks Financial Blog
1/5/2026
-
GuruFocus
1/5/2026
-
Business Wire
12/31/2025
-
MarketBeat
12/22/2025
-
TipRanks Financial Blog
12/22/2025
-
The Fly
12/19/2025
-
MarketBeat
12/4/2025
-
TipRanks Financial Blog
12/4/2025
-
GuruFocus
12/4/2025
-
The Fly
12/4/2025
-
Business Wire
11/30/2025
-
Simply Wall St
11/22/2025
-
MarketBeat
11/4/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, May 18, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
510 318 9098
Address
5858 Horton Street
EmeryVille, CA 94608
EmeryVille, CA 94608
Country
Year Founded
Business Description
Sector
Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company’s lead product candidate is...
more